Summary. Northern blot analysis of human tissues has demonstrated the expression of the brain-type glucose transporter isoform (GLUT 3) in liver, muscle and fat, raising the possibility that this transporter isoform may play a role in the regulation of glucose disposal in these tissues in response to insulin. We have raised an anti-peptide antibody against the C-terminal 13 amino acids of the murine homologue of this transporter isoform, and determined its tissue distribution in mouse tissues and murine-derived cell lines. The antibodies recoguise a glycoprotein of about 50 kilodaltons, expressed at high levels in murine brain. In contrast to human tissues, the expression of GLUT 3 in mice is restricted to the brain, and no immunoreactivity was observed in either liver, fat or muscle membranes, or in murine 3T3-L1 fibroblasts or adipocytes. In contrast, high levels of expression of this isoform were observed in the NG 108 neuroblastoma x glioma cell line, a hybrid cell derived from rat glioma and mouse neuroblastoma cells. Taken together, these data suggest that the expression of GLUT 3 in rodents is restricted to non-insulin responsive neuronal cells and hence it is likely that the factors regulating the expression of this transporter in rodents differ to those in humans.
Glucose is a major source of energy for mammalian cells, and a facilitative-diffusion type transport system for glucose is present in the plasma membrane of virtually all animal cells. Recent studies have shown that there is a family of glucose transport proteins, which exhibit considerable homology in their primary sequence, but which are expressed in a distinct, tissue-specific manner [1] [2] [3] . This tissue-specific pattern of expression can be rationalised by the specific roles of the particular tissue in the regulation of whole body glucose homeostasis. For example, tissues which exhibit acute insulin-stimulated glucose transport (muscle, fat and heart) express an isoform termed GLUT 4, (or the insulin-responsive transporter), and numerous studies have indicated that it is predominantly this isoform which accounts for the observed increased glucose transport rate in response to insulin [4] [5] [6] [7] [8] [9] [10] . Liver, the other major target tissue for insulin expresses a distinct transporter isoform, GLUT 2. This isoform has a high Km for glucose, which allows the rate of glucose release from the liver to be increased as the intracellular concentration of glucose is raised [11] [12] [13] .
To date, studies of the brain-type isoform, GLUT 3, have been restricted to Northern blot analysis in human tissues [14] . In humans, GLUT 3 is expressed at highest levels in the brain. However, its mRNA has also been observed in adipose tissue, liver and muscle, raising the possibility that this isoform may also be important in regulating glucose disposal by these tissues in response to insulin. Recent isolation of the murine cDNA encoding GLUT 3 homologue [15] represents an important advance, since many studies of peripheral insulin resistance utilise rodent models of diabetes and/or obesity, such as the db/db mouse or BB rat [16, 17] . Therefore, in an attempt to evaluate the role of GLUT 3 in glucose homeostasis, we have generated an antibody against the murine homologue of GLUT 3, and used this antibody to determine the sites of expression of GLUT 3 protein in mice, with particular emphasis on liver, muscle and adipose tissue.
Materials and methods

Materials
Peptides were synthesised by BioMac Ltd., Department of Biochemistry, University of Glasgow. Sulpho-MBS and ImmunoPure Columns and reagents were from Pierce (Chester, UK). Adjuvant shaking in 5 % (weight/volume) non-fat milk in wash buffer (PBS containing i retool/1 EDTA and 0.1% volume/volume Triton X-100) for 30min. The nitrocellulose was then transferred to 1% (weight/volume) non-fat milk in wash buffer containing antibody at 10 gg/ml and incubated overnight with shaking. Blots were then developed as described [18] . Fig.1 . Immunological identification of GLUT 3 in mouse brain. Panel a: Immunoblot of mouse brain membranes. 12 btg of mouse brain membranes were immunoblotted as described, and the blot probed with 10 ~tg/ml affinity purified anti-GLUT 3 antibodies. The relative position of molecular weight markers is shown to the right of the gel, the entire running gel is shown. Panel b: Effect of glycosidase treatment on GLUT 3.115 gg of mouse brain membranes were incubated in the presence (lane 2) or absence (lane 1) of neuraminidase and endoglycosidase F as described in the materials and methods. Samples containing equal amounts (20 gg) of membrane protein were then electrophoresed and immunoblotted as described was purchased from Difco laboratories (Detroit, Mich., USA).
[12~I]goat anti-rabbit IgG and [3H]cytochalasin B were from DuPont (Stevenage, UK). Cytochalasin B and E, and Protein A agarose were from Sigma (Poole, UK). Endoglycosidase F and neuraminidase were from Boehringer Mannheim GmbH (Lewes, UK). All other reagents were as described [13, 18, 19] .
Antisera production
A peptide corresponding to the C-terminal 13 amino acids of the murine homologue of GLUT3 [15] , sequence NH2-NSMQPVKETPGNA-COOH was coupled to keyhole limpet haemocyanin via sulpho-MBS, utilising an N-terminal cysteine residue incorporated into the peptide [20] . Rabbits were immunised with 250 gg of conjugated peptide in I ml of a 40/60 mixture of phosphate buffered saline (PBS: 150 mmol/1 NaC1, 10 mmol/1 sodium phosphate, pH 7.4)/Freunds complete adjuvant at multiple intradermal sites. One month later, animals were boosted with the same, but using incomplete Freunds adjuvant. Two weeks later, blood was collected. Antibodies were affinity purified over a column of immobilised peptide using the Pierce ImmunoPure system. Affinity purified antibodies were dialysed overnight against PBS and stored at -80 ~ prior to use. All experiments reported herein were performed using affinity purified antibodies. The affinity purified GLUT 1 antibodies were the gift of Dr. S. A. Baldwin, Royal Free Hospital, London UK. All antigen injections and sera production was performed by East Acre's Biologicals (Southbridge, Mass. USA).
Immunoblotting
Proteins were separated on sodium dodecyl sulphate-polyacrylamide gels (SDS-PAGE) as described previously [17] . Following electrophoresis, proteins were transferred to nitrocellulose at 250 mAmps for 2 to 3 h in 25 mmol/1 sodium phosphate, pH 6.5. Non-specific binding sites on the nitrocellulose were blocked by
Preparation of membranes
Mouse brain membranes. Intact mouse brain tissue was dissected from two mice, homogenised by 20 strokes of a dounce homogeniser in 10 ml of Tris-EDTA buffer (10 mmol/l Tris-HC1 pH 7.5, 1 mmol/1 EDTA). The homogenate was centrifuged at 2,500 x gmax for 10 min at 4~ and the supernatant collected. This supernatant was further centrifuged at 25,000 x gma• for 10 min at 4~ to pellet total membranes. The resulting pellet was washed in Tris-EDTA buffer, centrifuged at 25,000 x gm,x for 10 min at 4~ and the pellet resuspended in 5 ml of Tris-EDTA buffer, and frozen at -80~ prior to use.
Mouse liver membranes. Purified plasma membranes were prepared from total mouse liver homogenates exactly as previously described [21,221. 3T3-L1 adipocyte membranes. 3T3-L1 fibroblasts were grown in culture, and differentiated into adipocytes as previously described [23] . Membrane fractions corresponding to a crude plasma membrane fraction, a high density microsomal and low density microsomal fraction were prepared exactly as previously described [24] .
Neuroblastomax glioma NG 108 membranes. Neuroblastomax glioma cells were grown in culture and membranes prepared exactly as described [25] .
Glycosidase digestion. 115 gg of mouse brain membranes were resuspended in 50 mmol/1 potassium phosphate, pH 5.0, 20 mmoi/1 EDTA, 2 % Triton X-100, 0.2 % SDS, 1% 2-mercaptoethanol, and incubated for 48 h with 0.35 U N-glycosidase F and 5 ~g neuraminidase at 37 ~ Samples were briefly vortexed throughout the incubation. Following incubation, the proteins were precipitated using trichtoroacetic acid, resuspended in SDS-PAGE buffer (see above), and electrophoresed and immunoblotted as described.
R e s u l t s
Characterisation of rn G L U T 3 antibody. I m m u n o b l o t t i n g
of m e m b r a n e s from m o u s e brain with affinity-purified a n t i -G L U T 3 antibodies identified a m a j o r b a n d of Mr 50 kilodaltons (Fig. 1, p a n peptide competition experiments, we have shown that the major immunoreactive band in mouse brain at 50 kilodaltons was effectively competed by 10 gg/ml of the GLUT 3 peptide, but not by a similar concentration of a peptide corresponding to the C-terminal 14 amino acids of GLUT 1 (Fig. 2) . In addition, the anti-GLUT 1 antibodies recognise a protein of higher molecular weight (about 55 kilodaltons), and the anti-GLUT 1 signal was not affected by the inclusion of 5 gg/ml GLUT 3 peptide, but was effectively blocked by this concentration of GLUT 1 peptide (Fig. 2) . In experiments not shown here, we have demonstrated that the antibodies raised against the murine GLUT 3 isoform do not immunoblot GLUT 1 or the human isoform of GLUT 3 when expressed in Xenopus oocytes (G.W.Gould, unpublished observations). Taken together, these results indicate that the major immunoreactive protein at 50 kilodaltons recognised by the anti-mGLUT3 antibodies is indeed m G L U T 3.
The predicted amino acid sequence of the m G L U T 3 contains a potential site for N-linked glycosylation in the extracellular loop located between potential transmembrane helices 1 and 2. Accordingly, we have examined the effect of glycosidases on the electrophoretic mobility of m G L U T 3. Digestion of solubilised mouse brain membranes with the combination of N-glycosidase F and neuraminidase as described in the Materials and methods caused a decrease in the apparent molecular weight of GLUT 3 to 43 kilodaltons ( Fig. 1 panel b) , which is consistent with the removal of carbohydrate from the core polypeptide.
The distribution of m G L U T 3 was examined by immunoblotting various mouse tissues. No evidence of immunoreactivity at 50 kilodaltons was found in liver (Fig.3,  panel b ) or in membranes from the murine adipocyte cell line, 3T3-L1 adipocytes (Fig.3, panel a) . However, GLUT 1 was readily detected in the same amount of 3T3-L1 adipocyte membranes, and was also present in liver membranes (Fig. 3, panel d) . The major glucose transporter isoforms expressed in liver and adipocytes are GLUT 2 and GLUT 4 respectively; the data in Figure 3 , panel D demonstrates the expression of GLUT 2 in liver plasma membranes, and we and other laboratories have identified high levels of expression of GLUT 4 in 3T3-L1 adipocyte membranes (17) .
Skeletal muscle is an important site of peripheral glucose disposal. Consequently we have examined membranes from mouse soleus muscle to characterise transporter expression. The results (Fig. 4) show the expected high levels of GLUT 4 expression, with little or no detectable GLUT 1, and no detectable GLUT 3 expression in samples of 50 and 100 gg of membrane protein.
The proposal that the expression of GLUT 3 may be restricted to neuronal tissue prompted an examination of the neuroblastoma x glioma cell line, NG 108, a mouse x rat hybrid cell. Immunoblot analysis of this cell line, and also of the rat glioma parental cell is shown in Figure 5 , panel A; the mGLUT 3 band of 50 kilodaltons was observed in the hybrid cell line, but not in the glioma. The expression of GLUT 1 was readily detectable in identical amounts of membrane protein (Fig. 5, panel b) .
Discussion
The identification of a family of facilitative glucose transporters has led to a significant advance in the understanding of glucose homeostasis. Of the five glucose transporters cloned to date, all have been functionally expressed in a heterologous system [4, 11, 13, 19, 27, 28] , and their substrate selectivities and kinetics investigated [13] . To further elucidate the contribution of each transporter isoform in the regulation of glucose utilisation by any given tissue, we have raised a panel of anti-peptide antibodies against these different isoforms. The results reported herein concern the GLUT 3, or brain-type isoform. In humans, Northern blot analysis demonstrated the expression of this isoform in many tissues, with highest levels in the brain, but significant levels were also observed in liver, adipose tissue and muscle [14] . The recent isolation of the murine homologue of this isoform [15] prompted us to produce a specific antibody against the murine homologue of this isoform, and to examine the distribution of GLUT 3 in mouse tissues which play important roles in the regulation of blood homeostasis, liver, muscle and fat.
As shown, the antibody recognised a protein of molecular weight of about 50 kilodaltons in mouse brain membranes, which was subsequently shown to be a glucose transporter by the specific immunoprecipitation of D-glu- cose inhibitable cytochalasin B binding sites. The antibody also cross-reacted weakly with proteins of higher molecular weight, but these are unlikely to be glucose transporters, as we were unable to label these proteins with cytochalasin B or the photo-activatable glucose analogue, AMB-ATBA (data not shown). Glycosidase digestion, followed by immunoblotting indicated that mGLUT 3 contains an N-linked oligosaccharide, a characteristic feature of the facilitative glucose transporters.
The results of an immunoblot analysis of different murine tissues or cell lines is shown. We observed no immunoreactivity in purified liver plasma membranes, muscle membranes, or membranes prepared from murine 3T3-L1 adipocytes, a cell line often used in the study of insulin-stimulated glucose transport [23] . These data were surprising since Northern blot analysis of human tissues had shown the presence of the GLUT 3 mRNA in many tissues, with levels being highest in brain, but readily detectable in placenta, liver, fat and also present in muscle. These data suggested that the expression of GLUT 3 in mice may be restricted to a smaller subset of tissues. The possibility that mGLUT 3 expression was confined to neuronally-derived cells was examined. Our results also show that GLUT 3 is expressed in the neuroblastoma x glioma cell line, a hybrid cell derived from rat glioma and murine neuroblastoma cell lines; no immunoreactivity was observed in the parental rat gliomal cells, but GLUT 1 expression was readily detected in these cell lines. These results indicate that the expression of GLUT 3 in mice is restricted to the brain and neurallyderived tissues. It is conceivable that the apparent expression of GLUT 3 observed in liver, muscle and fat from humans may be due to a relatively richer supply of neuronal elements to these tissues in higher mammals.
It is well-established that the major glucose transporter expressed at the blood-nerve and blood-brain barrier is GLUT 1, the erythrocyte-type transporter [29] . Recent studies from this laboratory have examined the kinetics of the human isoforms of GLUT i and GLUT 3, and shown that these isoforms, when expressed in Xenopus oocytes, have Km's for 3-O-methyl-D-glucose of 17 and 10.6 mmol/1 respectively (measured under conditions of equilibrium exchange) [13] . In brain, under normal conditions the capacity of hexokinase for glucose (the prefered energy source) is considerably greater than the capacity of the glucose transport systems in this tissue [30] . However, it may be speculated that under conditions of high glucose demand or hypoglycaemia, the expression of a facilitative Acknowledgements. This work was supported by grants from the Juvenile Diabetes Foundation International, British Diabetic Association and the Wellcome Trust (to G. W. G.). We are grateful to Dr. G. Bell (University of Chicago) for providing us with the sequence of the murine GLUT 3 isoform prior to publication, to Dr. I. Mullaney and Mr. C. Carr (University of Glasgow) for generously providing us with NG 108 cells, and advice regarding mouse brain membrane preparation, and to Dr. S. Baldwin (Royal Free Hospital) for the gift of anti-GLUT i antibodies. Shown is an identical gel, but probed with anti-GLUT I antibodies glucose t r a n s p o r t e r in the brain with a low Km for hexoses would ensure an efficient u p t a k e of glucose, even when blood glucose is low.
In summary, we have shown that in murine tissues, the expression of the b r a i n -t y p e facilitative glucose transporter, G L U T 3, is restricted to the brain, and p r o b a b l y neurally-derived tissues. N o evidence for the expression of this p r o t e i n in liver, fat or muscle m e m b r a n e s was obtained. These results support the conclusions of Yano et al. [31] , who o b s e r v e d no expression of the G L U T 3 isoform in m u r i n e tissues o t h e r than the brain by N o r t h e r n blotting using the h u m a n G L U T 3 c D N A as a probe. However, unlike G L U T s 1, 2 or 4, the h u m a n and murine h o m o l o g u e s of G L U T 3 differ, showing only 83 % identity [19] , c o m p a r e d to the greater than 95% identity in the case of G L U T 1 [1] [2] [3] . Consequently, the results p r e s e n t e d here using a species-specific p r o b e for the expressed p r o t e i n provide further s u p p o r t for this group's
